Veninga T S, Dankert J, Ebels E J, Fidler V J
Acta Radiol Oncol. 1984;23(1):69-73. doi: 10.3109/02841868409135989.
Concomitant application of intrathecal methotrexate (MTX) and cranial irradiation has been described as being able to cause brain abnormalities in patients with leukemia. In the investigation presented, rabbits were treated once weekly for 6 weeks with intraventricular MTX and irradiation. Cerebrospinal fluid (CSF) sampled at various time points after each treatment contained for the samples obtained 4 hours after treatment increasing amounts of MTX. This indicated a retardation in MTX clearance from the CSF. Such a retardation might contribute to the generation of brain abnormalities, although no data have as yet been obtained to prove this suggestion.
鞘内注射甲氨蝶呤(MTX)与颅脑照射同时应用已被描述为可导致白血病患者出现脑部异常。在本研究中,给兔子每周进行一次脑室内MTX注射和照射,持续6周。每次治疗后在不同时间点采集的脑脊液(CSF)样本显示,治疗后4小时采集的样本中MTX含量逐渐增加。这表明MTX从脑脊液中的清除延迟。尽管尚未获得数据来证实这一推测,但这种清除延迟可能会导致脑部异常的发生。